Nucleis is a radiopharmaceutical company which proposes and manufactures Radiopharmaceutical Drugs for Diagnostic and Therapy Monitoring. Nucleis is a spin-off from the University of Liège (Cyclotron Research Centre – Belgium) created to outsource the GMP manufacturing and distribution of PET (*Positron Emission Tomography) radiopharmaceutical drugs.